Jin Yang

机构：Chongqing Academy of Environmental Science, Chongqing Medical University

发表论文 42 篇 · 总被引 1239 次 · h-index 12

代表论文

• Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial (2021 · The Lancet Oncology · 被引 404)
• Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial (2023 · BMJ · 被引 87)
• Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review (2022 · Frontiers in Oncology · 被引 15)
• Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial (2024 · EClinicalMedicine · 被引 11)
• Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer (2021 · Cancer Management and Research · 被引 10)
• The non-invasive evaluation technique of patellofemoral joint stress: a systematic literature review (2023 · Frontiers in Bioengineering and Biotechnology · 被引 7)